Skip to main content
. 2023 Aug 11;42(37):2737–2750. doi: 10.1038/s41388-023-02781-9

Fig. 6. JMJD6 regulates macrophage activation through STAT3/IL-10 pathway.

Fig. 6

a Western blot assays on the level of phosphorylated STAT3 in total protein extracts from BMDMs (the up panel) or M0-like THP-1 cells (the down panel). b The expression levels of STAT3 and p-STAT3Y705 were detected in total protein extracted from BMDMs (the up panel) or M0-like THP-1 cells (the down panel) after 6 h stimulation by tumor-CM. c Co-IP assay on the expression of STAT3 protein and JMJD6 protein in TAM-like THP-1 cells. d GST pull-down assays on JMJD6-His and STAT3-GST. e Western blot assays on the purified recombinant STAT3 proteins (1–7.5 μg/lane) were incubated with purified recombinant JMJD6 proteins (1–7.5 μg/lane) in an in vitro phosphorylation system. f Inhibitory effect of napabucasin on phosphorylation of Y705 residue of STAT3 protein in macrophages. g Napabucasin inhibited the production of IL-10 protein in tumor-CM-stimulated macrophages. h Napabucasin inhibited the secretion of IL-10 in macrophage supernatant. Data represent mean ± SD (n = 3). ns: no significant difference, ***P < 0.001.